MedTrace Logo

Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases

NCT05488860 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2022-08-05

No results posted yet for this study

Summary

Piezoelectric drived microneedling treats refractory skin disorders using hollow microneedles assisted by ultrasound. Mechanically, the injection of medicine by hollow microneedling could makes the distribution of medicine more evenly. And the addition of ultrasound technique improves the effectiveness of microneedling. Investigators plan to conduct a pilot study to investigate the efficacy of using piezoelectric drived microneedles in treating refractory skin diseases.

Conditions

  • Skin Diseases
  • Hypertrophic Scar
  • Keloid
  • Plantar Wart
  • Warts
  • Skin Tumor

Interventions

DRUG

Triamcinolone acetonide(scar)/5-ALA(others)

For scar, the drug is triamcinolone acetonide.

PROCEDURE

Piezoelectric drived microneedling

Piezoelectric drived microneedling

DRUG

5-ALA (a photosensitizer for photodynamic therapy).

For other diseases, the drug is 5-ALA (a photosensitizer for photodynamic therapy).

Sponsors & Collaborators

  • Xiangya Hospital of Central South University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-30
Primary Completion
2024-06-30
Completion
2024-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05488860 on ClinicalTrials.gov